

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | 1 | 1 | — | — | — | 1 |
| Squamous cell carcinoma | D002294 | — | — | 1 | 1 | — | — | — | 1 |
| Neoplasms | D009369 | — | C80 | — | 1 | — | — | — | 1 |
| Carcinoma in situ | D002278 | — | D09.9 | — | 1 | — | — | — | 1 |
| Cervical intraepithelial neoplasia | — | — | D06 | — | 1 | — | — | — | 1 |
| Uterine cervical dysplasia | D002578 | EFO_1000910 | N87 | — | 1 | — | — | — | 1 |
| Drug common name | TIPAPKINOGENE SOVACIVEC |
| INN | tipapkinogene sovacivec |
| Description | Tipapkinogene sovacivec is a gene pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Gene |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108714 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | P34L5Y2SR5 (ChemIDplus, GSRS) |
